Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
conference entities : Athira pharma, inc. save search
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
Published: 2024-03-08 (Crawled : 12:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.0%
H: 1.45%
C: -13.73%
fosgonimeton pharma conference alzheimer’s international preclinical parkinson’s potential
Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
Published: 2023-11-29 (Crawled : 12:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.69%
H: 2.76%
C: -3.1%
pharma conference
Athira Pharma to Participate in Jefferies London Healthcare Conference
Published: 2023-11-08 (Crawled : 12:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 3.31%
H: 0.0%
C: -3.85%
pharma conference
Athira Pharma to Participate in Upcoming October Conferences
Published: 2023-09-28 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.53%
H: 6.35%
C: 5.82%
pharma
Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
Published: 2023-09-19 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.0%
H: 5.13%
C: 4.62%
pharma conference global
Athira Pharma Announces Upcoming Presentations at the Alzheimer’s Association International Conference (AAIC) 2023
Published: 2023-07-06 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: -2.13%
pharma conference association alzheimer’s international
Athira Pharma to Participate in Upcoming June Conferences
Published: 2023-05-31 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.0%
H: 3.7%
C: 2.59%
pharma
Athira Pharma to Participate in Upcoming May Investor Conferences
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.34%
H: 0.68%
C: -3.05%
pharma
Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of Fosgonimeton for Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2023 International Conference
Published: 2023-03-28 (Crawled : 06:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.0%
H: 0.78%
C: -4.64%
fosgonimeton pharma conference alzheimer’s international preclinical parkinson’s potential
Athira Pharma to Present at Upcoming Neuroscience Focused Investor Conferences
Published: 2023-03-08 (Crawled : 14:00) - biospace.com/
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.61%
pharma
Athira Pharma to Present Data Supporting Therapeutic Potential of Enhancing HGF/MET Neurotrophic System at Upcoming Scientific Conferences
Published: 2023-03-06 (Crawled : 12:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.47%
pharma system potential
Athira Pharma Highlights Therapeutic Potential of Fosgonimeton in Presentation of Additional Biomarker Data in Mild-to-Moderate Alzheimer’s Disease Patients from ACT-AD Phase 2 Study at CTAD Conference
Published: 2022-11-29 (Crawled : 19:00) - biospace.com/
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.35%
H: 3.53%
C: 1.41%
pharma conference disease biomarker alzheimer’s presentation potential study fosgonimeton
Athira Pharma to Present Additional Biomarker Data from ACT-AD Phase 2 Study of Fosgonimeton at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Published: 2022-11-21 (Crawled : 13:20) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.31%
H: 1.56%
C: -0.31%
pharma trials conference disease biomarker alzheimer’s study fosgonimeton phase 2
Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of HGF/MET Platform at Neuroscience 2022 Conference
Published: 2022-11-16 (Crawled : 12:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -2.54%
H: 5.7%
C: 0.33%
pharma conference preclinical potential platform
Athira Pharma to Present at Stifel 2022 Healthcare Conference
Published: 2022-11-09 (Crawled : 12:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -1.68%
H: 0.17%
C: -5.48%
pharma conference
Athira Pharma to Present Preclinical Data Highlighting Therapeutic Potential of HGF/MET Platform in Neurodegenerative Disorders at Neuroscience 2022 Conference
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 1.34%
H: 1.32%
C: -0.33%
pharma conference preclinical neurodegenerative potential platform
Athira Pharma Presents Data from ACT-AD Phase 2 Proof-of-Concept Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients at the Alzheimer's Association International Conference 2022
Published: 2022-08-03 (Crawled : 16:00) - biospace.com/
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -2.65%
H: 9.39%
C: 5.45%
pharma conference alzheimer's alzheimer’s international study fosgonimeton
Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022
Published: 2022-08-02 (Crawled : 20:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -2.65%
H: 9.39%
C: 5.45%
pharma conference preclinical alzheimer's international
Athira Pharma to Host Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call on March 24, 2022
Published: 2022-03-17 (Crawled : 19:00) - biospace.com/
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.2%
H: 0.89%
C: -0.2%
financial results conference results
Athira Pharma Presents Overview and Update from ACT-AD and LIFT-AD Trials of ATH-1017 in mild-to-moderate Alzheimer’s Disease at CTAD Conference
Published: 2021-11-10 (Crawled : 17:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.65%
H: 2.92%
C: -3.51%
disease alzheimer ath-1017 trials trial conference alzheimer’s alzheimer's disease alzheimer's
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
DV | News | $29.43 -2.36% 0.24% 1.9M
|
Information
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
ML 4 | $69.13 -4.48% -1.64% 110K
|
Your saved searches
Save your searches and get alerts when important news are released.